ALEXION PHARMACEUTICALS, INC. Insider Trading for March 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALEXION PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ALEXION PHARMACEUTICALS, INC. for March 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 05 2019 | ALXN | ALEXION PHARMACEUT ... | HANTSON LUDWIG | CEO | Grant | A | 0.00 | 37,198 | 0 | 170,836 | 133.6 K to 170.8 K (+27.83 %) |
| Mar 05 2019 | ALXN | ALEXION PHARMACEUT ... | SARIN ARADHANA | Chief Strategy & Bu ... | Grant | A | 0.00 | 8,250 | 0 | 30,779 | 22.5 K to 30.8 K (+36.62 %) |
| Mar 05 2019 | ALXN | ALEXION PHARMACEUT ... | Franchini Indrani Lall | EVP, Chief Complian ... | Grant | A | 0.00 | 8,250 | 0 | 35,531 | 27.3 K to 35.5 K (+30.24 %) |
| Mar 05 2019 | ALXN | ALEXION PHARMACEUT ... | Goff Brian | EVP & Chief Commerc ... | Grant | A | 0.00 | 9,428 | 0 | 43,419 | 34 K to 43.4 K (+27.74 %) |
| Mar 05 2019 | ALXN | ALEXION PHARMACEUT ... | ORLOFF JOHN J | EVP, Research & Dev ... | Grant | A | 0.00 | 9,428 | 0 | 40,577 | 31.1 K to 40.6 K (+30.27 %) |
| Mar 05 2019 | ALXN | ALEXION PHARMACEUT ... | Bazarko Daniel | SVP, Controller, CA ... | Grant | A | 0.00 | 3,403 | 0 | 7,543 | 4.1 K to 7.5 K (+82.20 %) |
| Mar 05 2019 | ALXN | ALEXION PHARMACEUT ... | Chiniara Ellen | EVP & General Couns ... | Grant | A | 0.00 | 8,250 | 0 | 15,961 | 7.7 K to 16 K (+106.99 %) |
| Mar 05 2019 | ALXN | ALEXION PHARMACEUT ... | Clancy Paul J | EVP, Chief Financia ... | Grant | A | 0.00 | 9,428 | 0 | 95,677 | 86.2 K to 95.7 K (+10.93 %) |
| Mar 05 2019 | ALXN | ALEXION PHARMACEUT ... | LAW ANNE-MARIE | EVP, Chief Experien ... | Grant | A | 0.00 | 8,839 | 0 | 37,655 | 28.8 K to 37.7 K (+30.67 %) |
| Mar 04 2019 | ALXN | ALEXION PHARMACEUT ... | SARIN ARADHANA | Chief Strategy & Bu ... | Payment of Exercise | F | 132.92 | 267 | 35,490 | 22,529 | 22.8 K to 22.5 K (-1.17 %) |
| Mar 04 2019 | ALXN | ALEXION PHARMACEUT ... | Chiniara Ellen | EVP & General Couns ... | Payment of Exercise | F | 132.92 | 633 | 84,138 | 7,711 | 8.3 K to 7.7 K (-7.59 %) |
| Mar 04 2019 | ALXN | ALEXION PHARMACEUT ... | ORLOFF JOHN J | EVP, Research & Dev ... | Grant | A | 93.01 | 34 | 3,162 | 31,149 | 31.1 K to 31.1 K (+0.11 %) |
| Mar 04 2019 | ALXN | ALEXION PHARMACEUT ... | ORLOFF JOHN J | EVP, Research & Dev ... | Payment of Exercise | F | 132.92 | 675 | 89,721 | 31,115 | 31.8 K to 31.1 K (-2.12 %) |
| Mar 04 2019 | ALXN | ALEXION PHARMACEUT ... | LAW ANNE-MARIE | EVP, Chief Experien ... | Payment of Exercise | F | 132.93 | 634 | 84,278 | 28,816 | 29.5 K to 28.8 K (-2.15 %) |
| Mar 04 2019 | ALXN | ALEXION PHARMACEUT ... | HANTSON LUDWIG | CEO | Payment of Exercise | F | 132.92 | 4,043 | 537,396 | 133,638 | 137.7 K to 133.6 K (-2.94 %) |
| Mar 04 2019 | ALXN | ALEXION PHARMACEUT ... | Clancy Paul J | EVP, Chief Financia ... | Payment of Exercise | F | 132.93 | 1,079 | 143,431 | 86,249 | 87.3 K to 86.2 K (-1.24 %) |
| Mar 04 2019 | ALXN | ALEXION PHARMACEUT ... | Goff Brian | EVP & Chief Commerc ... | Payment of Exercise | F | 132.93 | 670 | 89,063 | 33,991 | 34.7 K to 34 K (-1.93 %) |
| Mar 04 2019 | ALXN | ALEXION PHARMACEUT ... | Franchini Indrani Lall | EVP, Chief Complian ... | Payment of Exercise | F | 132.93 | 625 | 83,081 | 27,281 | 27.9 K to 27.3 K (-2.24 %) |
| Mar 04 2019 | ALXN | ALEXION PHARMACEUT ... | Bazarko Daniel | SVP, Controller, CA ... | Payment of Exercise | F | 132.92 | 381 | 50,643 | 4,140 | 4.5 K to 4.1 K (-8.43 %) |
| Mar 04 2019 | ALXN | ALEXION PHARMACEUT ... | Bazarko Daniel | SVP, Controller, CA ... | Payment of Exercise | F | 132.92 | 216 | 28,711 | 4,521 | 4.7 K to 4.5 K (-4.56 %) |
| Mar 01 2019 | ALXN | ALEXION PHARMACEUT ... | Bazarko Daniel | SVP, Controller, CA ... | Payment of Exercise | F | 135.58 | 70 | 9,491 | 4,737 | 4.8 K to 4.7 K (-1.46 %) |